MCI patients declining and not-declining at Mid-Term follow-up

FDG-PET findings

M. Pagani, B. Dessi, S. Morbelli, A. Brugnolo, D. Salmaso, A. Piccini, D. Mazzei, G. Villavecchia, S. A. Larsson, G. Rodriguez, F. Nobili

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Patients with Mild Cognitive Impairment (MCI) not converted to dementia at one to three years follow-up represent an heterogeneous group across studies, by including 'late converters' but also patients without any neurodegenerative disease. We tested the hypothesis that the combination of memory and brain metabolic assessment could identify subgroups of memory decliners (MCI/Decl) and non-decliners (MCI/noDecl) before a long follow-up time is available. From twenty-nine patients with amnestic MCI (aMCI) at baseline, three groups were identified at follow-up: 10 patients who converted to AD (MCI/AD); 10 patients either showing episodic memory worsening or reaching the floor effect on memory and declining in other key tests (MCI/Decl) and 9 patients showing no memory worsening or even improvement (MCI/noDecl). They were compared with a group of fourteen elderly controls (CTR) by means of basal FDG-PET voxelbased analysis (SPM2). Two hypometabolic clusters were found in MCI/AD versus CTR, including the bilateral posterior cingulate cortex, the left parietal precuneus and the left fusiform gyrus. MCI/AD showed also a large hypometabolic region, mainly including the left medium and superior temporal gyri and inferior parietal lobule, when compared to MCI/noDecl. The MCI/Decl showed a hypometabolic region in the left medial temporal lobe versus both CTR (hippocampus) and MCI/noDecl (parahippocampal gyrus and hippocampus). No significant difference was found in the comparison between CTR and MCI/noDecl, neither in the comparison between MCI/Decl and MCI/AD. Thus, non converter MCI patients comprised a sub-group of 'decliners' with AD-like metabolic and cognitive patterns, likely including 'late converters', and a sub-group lacking this pattern, with stable or improving memory function and a brain metabolic picture similar to that in healthy controls. Combining neuropsychological and FDG-PET information could be used for prognostic purposes in aMCI patients at medium-term follow-up.

Original languageEnglish
Pages (from-to)287-294
Number of pages8
JournalCurrent Alzheimer Research
Volume7
Issue number4
DOIs
Publication statusPublished - 2010

Fingerprint

Temporal Lobe
Parahippocampal Gyrus
Parietal Lobe
Cognitive Dysfunction
Episodic Memory
Gyrus Cinguli
Brain
Neurodegenerative Diseases
Dementia
Hippocampus

Keywords

  • Alzheimer's disease
  • Amnestic mild cognitive impairment
  • Episodic memory
  • Fdg-pet

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

MCI patients declining and not-declining at Mid-Term follow-up : FDG-PET findings. / Pagani, M.; Dessi, B.; Morbelli, S.; Brugnolo, A.; Salmaso, D.; Piccini, A.; Mazzei, D.; Villavecchia, G.; Larsson, S. A.; Rodriguez, G.; Nobili, F.

In: Current Alzheimer Research, Vol. 7, No. 4, 2010, p. 287-294.

Research output: Contribution to journalArticle

Pagani, M, Dessi, B, Morbelli, S, Brugnolo, A, Salmaso, D, Piccini, A, Mazzei, D, Villavecchia, G, Larsson, SA, Rodriguez, G & Nobili, F 2010, 'MCI patients declining and not-declining at Mid-Term follow-up: FDG-PET findings', Current Alzheimer Research, vol. 7, no. 4, pp. 287-294. https://doi.org/10.2174/156720510791162368
Pagani, M. ; Dessi, B. ; Morbelli, S. ; Brugnolo, A. ; Salmaso, D. ; Piccini, A. ; Mazzei, D. ; Villavecchia, G. ; Larsson, S. A. ; Rodriguez, G. ; Nobili, F. / MCI patients declining and not-declining at Mid-Term follow-up : FDG-PET findings. In: Current Alzheimer Research. 2010 ; Vol. 7, No. 4. pp. 287-294.
@article{e149aca19c6f4e7aa9cf632e9ee30316,
title = "MCI patients declining and not-declining at Mid-Term follow-up: FDG-PET findings",
abstract = "Patients with Mild Cognitive Impairment (MCI) not converted to dementia at one to three years follow-up represent an heterogeneous group across studies, by including 'late converters' but also patients without any neurodegenerative disease. We tested the hypothesis that the combination of memory and brain metabolic assessment could identify subgroups of memory decliners (MCI/Decl) and non-decliners (MCI/noDecl) before a long follow-up time is available. From twenty-nine patients with amnestic MCI (aMCI) at baseline, three groups were identified at follow-up: 10 patients who converted to AD (MCI/AD); 10 patients either showing episodic memory worsening or reaching the floor effect on memory and declining in other key tests (MCI/Decl) and 9 patients showing no memory worsening or even improvement (MCI/noDecl). They were compared with a group of fourteen elderly controls (CTR) by means of basal FDG-PET voxelbased analysis (SPM2). Two hypometabolic clusters were found in MCI/AD versus CTR, including the bilateral posterior cingulate cortex, the left parietal precuneus and the left fusiform gyrus. MCI/AD showed also a large hypometabolic region, mainly including the left medium and superior temporal gyri and inferior parietal lobule, when compared to MCI/noDecl. The MCI/Decl showed a hypometabolic region in the left medial temporal lobe versus both CTR (hippocampus) and MCI/noDecl (parahippocampal gyrus and hippocampus). No significant difference was found in the comparison between CTR and MCI/noDecl, neither in the comparison between MCI/Decl and MCI/AD. Thus, non converter MCI patients comprised a sub-group of 'decliners' with AD-like metabolic and cognitive patterns, likely including 'late converters', and a sub-group lacking this pattern, with stable or improving memory function and a brain metabolic picture similar to that in healthy controls. Combining neuropsychological and FDG-PET information could be used for prognostic purposes in aMCI patients at medium-term follow-up.",
keywords = "Alzheimer's disease, Amnestic mild cognitive impairment, Episodic memory, Fdg-pet",
author = "M. Pagani and B. Dessi and S. Morbelli and A. Brugnolo and D. Salmaso and A. Piccini and D. Mazzei and G. Villavecchia and Larsson, {S. A.} and G. Rodriguez and F. Nobili",
year = "2010",
doi = "10.2174/156720510791162368",
language = "English",
volume = "7",
pages = "287--294",
journal = "Current Alzheimer Research",
issn = "1567-2050",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - MCI patients declining and not-declining at Mid-Term follow-up

T2 - FDG-PET findings

AU - Pagani, M.

AU - Dessi, B.

AU - Morbelli, S.

AU - Brugnolo, A.

AU - Salmaso, D.

AU - Piccini, A.

AU - Mazzei, D.

AU - Villavecchia, G.

AU - Larsson, S. A.

AU - Rodriguez, G.

AU - Nobili, F.

PY - 2010

Y1 - 2010

N2 - Patients with Mild Cognitive Impairment (MCI) not converted to dementia at one to three years follow-up represent an heterogeneous group across studies, by including 'late converters' but also patients without any neurodegenerative disease. We tested the hypothesis that the combination of memory and brain metabolic assessment could identify subgroups of memory decliners (MCI/Decl) and non-decliners (MCI/noDecl) before a long follow-up time is available. From twenty-nine patients with amnestic MCI (aMCI) at baseline, three groups were identified at follow-up: 10 patients who converted to AD (MCI/AD); 10 patients either showing episodic memory worsening or reaching the floor effect on memory and declining in other key tests (MCI/Decl) and 9 patients showing no memory worsening or even improvement (MCI/noDecl). They were compared with a group of fourteen elderly controls (CTR) by means of basal FDG-PET voxelbased analysis (SPM2). Two hypometabolic clusters were found in MCI/AD versus CTR, including the bilateral posterior cingulate cortex, the left parietal precuneus and the left fusiform gyrus. MCI/AD showed also a large hypometabolic region, mainly including the left medium and superior temporal gyri and inferior parietal lobule, when compared to MCI/noDecl. The MCI/Decl showed a hypometabolic region in the left medial temporal lobe versus both CTR (hippocampus) and MCI/noDecl (parahippocampal gyrus and hippocampus). No significant difference was found in the comparison between CTR and MCI/noDecl, neither in the comparison between MCI/Decl and MCI/AD. Thus, non converter MCI patients comprised a sub-group of 'decliners' with AD-like metabolic and cognitive patterns, likely including 'late converters', and a sub-group lacking this pattern, with stable or improving memory function and a brain metabolic picture similar to that in healthy controls. Combining neuropsychological and FDG-PET information could be used for prognostic purposes in aMCI patients at medium-term follow-up.

AB - Patients with Mild Cognitive Impairment (MCI) not converted to dementia at one to three years follow-up represent an heterogeneous group across studies, by including 'late converters' but also patients without any neurodegenerative disease. We tested the hypothesis that the combination of memory and brain metabolic assessment could identify subgroups of memory decliners (MCI/Decl) and non-decliners (MCI/noDecl) before a long follow-up time is available. From twenty-nine patients with amnestic MCI (aMCI) at baseline, three groups were identified at follow-up: 10 patients who converted to AD (MCI/AD); 10 patients either showing episodic memory worsening or reaching the floor effect on memory and declining in other key tests (MCI/Decl) and 9 patients showing no memory worsening or even improvement (MCI/noDecl). They were compared with a group of fourteen elderly controls (CTR) by means of basal FDG-PET voxelbased analysis (SPM2). Two hypometabolic clusters were found in MCI/AD versus CTR, including the bilateral posterior cingulate cortex, the left parietal precuneus and the left fusiform gyrus. MCI/AD showed also a large hypometabolic region, mainly including the left medium and superior temporal gyri and inferior parietal lobule, when compared to MCI/noDecl. The MCI/Decl showed a hypometabolic region in the left medial temporal lobe versus both CTR (hippocampus) and MCI/noDecl (parahippocampal gyrus and hippocampus). No significant difference was found in the comparison between CTR and MCI/noDecl, neither in the comparison between MCI/Decl and MCI/AD. Thus, non converter MCI patients comprised a sub-group of 'decliners' with AD-like metabolic and cognitive patterns, likely including 'late converters', and a sub-group lacking this pattern, with stable or improving memory function and a brain metabolic picture similar to that in healthy controls. Combining neuropsychological and FDG-PET information could be used for prognostic purposes in aMCI patients at medium-term follow-up.

KW - Alzheimer's disease

KW - Amnestic mild cognitive impairment

KW - Episodic memory

KW - Fdg-pet

UR - http://www.scopus.com/inward/record.url?scp=77953963850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953963850&partnerID=8YFLogxK

U2 - 10.2174/156720510791162368

DO - 10.2174/156720510791162368

M3 - Article

VL - 7

SP - 287

EP - 294

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1567-2050

IS - 4

ER -